WILMINGTON, Del.--(BUSINESS WIRE)-- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s proprietary computational pathology platform, ...

NEW YORK--(BUSINESS WIRE)--Paige, a pioneer in AI-driven pathology solutions designed to improve the fight against cancer, today announced the open-source release of Paige’s Foundation Models, Open ...

In a recent study published in Nature Medicine, researchers demonstrated the use of the foundational model Virchow for computational analysis of pathological reports, prediction of biomarkers, and ...

Scientists have used computational tools, including machine learning, to differentiate between subtypes of rheumatoid arthritis. In this study, which was reported in Nature Communications, the ...

Traditional task-specific computational pathology models require a substantial labeled dataset for training to perform various tasks, while foundation models can be trained on large-scale, unlabeled ...

Casdin Capital and Johnson & Johnson Innovation – JJDC, Inc. led financing Company has raised over $195 million to date Funds will accelerate development of AI-based clinical applications, biomarkers ...

Researchers present Tripath: new, deep learning models that can use 3D pathology datasets to make clinical outcome predictions. The research team imaged curated prostate cancer specimens, using two 3D ...

Foundation models, advanced artificial intelligence systems trained on large-scale datasets, hold the potential to provide unprecedented advancements for the medical field. In computational pathology ...

Paige.AI, a health technology company that applies artificial intelligence to pathology for cancer diagnosis and treatment, recently announced it landed $25 million in Series A funding, led by Jim ...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)-- Results from an exploratory analysis of the TROPION-Lung01 phase 3 trial showed TROP2 as measured by quantitative continuous scoring (QCS), AstraZeneca’s ...